X4 Pharmaceuticals, Inc. (XFOR)
3.72
-0.13
(-3.38%)
USD |
NASDAQ |
Jun 10, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals Gross Profit Margin (Quarterly) : 76.59% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 76.59% |
| December 31, 2025 | 84.93% |
| September 30, 2025 | 78.81% |
| June 30, 2025 | 74.96% |
| March 31, 2025 | 82.63% |
| December 31, 2024 | 73.01% |
| September 30, 2024 | 45.18% |
| June 30, 2024 | 17.94% |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 |
| Date | Value |
|---|---|
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -112.5% |
| Return on Assets | -51.97% |
| Return on Invested Capital | -59.98% |
| Profit Margin (Quarterly) | -747.5% |
| Operating Margin (Quarterly) | -749.9% |
| Return on Net Operating Assets | -294.3% |